Cargando…
Correction to: Inebilizumab: A Review in Neuromyelitis Optica Spectrum Disorder
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653353/ https://www.ncbi.nlm.nih.gov/pubmed/36190651 http://dx.doi.org/10.1007/s40263-022-00957-7 |
| _version_ | 1784828662297657344 |
|---|---|
| author | Nie, Tina Blair, Hannah A. |
| author_facet | Nie, Tina Blair, Hannah A. |
| author_sort | Nie, Tina |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9653353 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96533532022-11-15 Correction to: Inebilizumab: A Review in Neuromyelitis Optica Spectrum Disorder Nie, Tina Blair, Hannah A. CNS Drugs Correction Springer International Publishing 2022-10-03 2022 /pmc/articles/PMC9653353/ /pubmed/36190651 http://dx.doi.org/10.1007/s40263-022-00957-7 Text en © Springer Nature 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Correction Nie, Tina Blair, Hannah A. Correction to: Inebilizumab: A Review in Neuromyelitis Optica Spectrum Disorder |
| title | Correction to: Inebilizumab: A Review in Neuromyelitis Optica Spectrum Disorder |
| title_full | Correction to: Inebilizumab: A Review in Neuromyelitis Optica Spectrum Disorder |
| title_fullStr | Correction to: Inebilizumab: A Review in Neuromyelitis Optica Spectrum Disorder |
| title_full_unstemmed | Correction to: Inebilizumab: A Review in Neuromyelitis Optica Spectrum Disorder |
| title_short | Correction to: Inebilizumab: A Review in Neuromyelitis Optica Spectrum Disorder |
| title_sort | correction to: inebilizumab: a review in neuromyelitis optica spectrum disorder |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653353/ https://www.ncbi.nlm.nih.gov/pubmed/36190651 http://dx.doi.org/10.1007/s40263-022-00957-7 |
| work_keys_str_mv | AT nietina correctiontoinebilizumabareviewinneuromyelitisopticaspectrumdisorder AT blairhannaha correctiontoinebilizumabareviewinneuromyelitisopticaspectrumdisorder |